Samuel Horr, MD
Interventional Cardiology · Nashville, TNNPI 1417273061
Payments from drug & device makers
Across 1,040 payments — averaging $877.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$359K
- Abbott$251K
- Boston Scientific$116K
- Edwards Lifesciences$76K
- Stryker$65K
- Inquis Medical, Inc.$34K
- plus $12K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 374 | $358,525 |
| Abbott | 189 | $250,948 |
| Boston Scientific | 150 | $115,586 |
| Edwards Lifesciences | 131 | $75,602 |
| Stryker | 52 | $65,389 |
| Inquis Medical, Inc. | 25 | $34,163 |
| Abiomed | 8 | $3,516 |
| Penumbra, Inc. | 10 | $2,554 |
| Biosense Webster, Inc. | 5 | $1,312 |
| Medtronic(2 entities) | 16 | $1,100 |
| Cardiva Medical, Inc. | 6 | $890 |
| Endovascular Engineering Inc. | 1 | $500 |
| Opsens Inc. | 5 | $475 |
| Shockwave Medical, Inc | 16 | $460 |
| Pfizer | 17 | $274 |
| Johnson & Johnson | 3 | $150 |
| AstraZeneca | 3 | $115 |
| Biolife, L.L.C. | 1 | $110 |
| EKOS Corporation | 2 | $103 |
| Spectrawave, Inc | 3 | $93 |
| Novo Nordisk | 3 | $74 |
| Imperative Care, Inc | 1 | $58 |
| Cardiac Dimensions, Inc. | 2 | $50 |
| Amgen | 3 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $37 |
| E.r. Squibb & Sons, L.L.C. | 1 | $35 |
| Novartis | 2 | $26 |
| Thrombolex, Inc. | 1 | $25 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Heartflow, Inc. | 1 | $20 |
| Philips North America LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
How this compares
$912,332 in reported general payments places this provider in the 95th percentile of 207 interventional cardiology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Nashville
- Michael MorseNashville$3.5M
- Colin BarkerNashville$2.1M
- Brian JeffersonNashville$2.1M
- Kashish GoelNashville$1.1M
- Jimmy KerriganNashville$769K
- Andrew GoodmanNashville$628K
- Nadia SuttonNashville$418K
- Bimal PadaliyaNashville$363K
- John RiddickNashville$288K
- Mark KoenigNashville$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.